Two different PABPN1 expanded alleles in a Mexican population with oculopharyngeal muscular dystrophy arising from independent founder effects

British Journal of Ophthalmology

Volumn 92, Issue 7, 2008, Pages 998-1002

  Rivera, D ^a   Mejia Lopez, H ^a   Pompa Mera, E N ^b   Villanueva Mendoza, C ^c   Nava Castaneda A ^a   Garnica Hayashi, L ^a   Cuevas Covarrubias, S ^d   Zenteno, J C ^a  

^a INSTITUTE OF OPHTHALMOLOGY CONDE DE VALENCIANA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c HOSPITAL DR LUIS SÁNCHEZ BULNES   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; FEMALE; FOUNDER EFFECT; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HISPANIC; HUMAN; MALE; MOLECULAR BIOLOGY; MUTANT; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPHTHALMOLOGY; PABPN1 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 47049107609     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.131482     Document Type: Article

References (24)

1. Brais B. Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease. Cytogenet Genome Res 2003;100:252-60.
2. Taylor EW. Progressive vagus-glossopharyngeal paralysis with ptosis. Contribution to group of family diseases. J Nerv Ment Dis 1915;42:129-39.
3. Victor M, Hayes R, Adams RD. Oculopharyngeal muscular dystrophy. A familial disease of late life characterized by dysphagia and progressive ptosis of the eyelids. N Engl J Med 1962;267:1267-72.
4. Blumen SC, Nisipeanu P. Sadeh M,et al. Epidemiology and inheritance of oculopharyngeal muscular dystrophy in Israel. Neuromuscul Disord 1997;7:S38-40.
5. Brais B, Rouleau GA, Bouchard JP,et al. Oculopharyngeal muscular dystrophy. Sem Neurol 1999;19:59-66.
6. Tomó FMS, Chateau D, Helbling-Leclerc A,et al. Morphological changes in muscle fibers inoculopharyngeal muscular dystrophy. Neuromuscul Disord 1997;7:S63-9.
7. Habbar S, Webberley MJ, Lunt P,et al. Siblings with recessive oculopharyngeal muscular dystrophy. Neuromuscul Disord 2007;17:254-7.
8. Semmler A, Kress W, Vielhaber S,et al. Variability of the recessive oculopharyngeal muscular dystrophy phenotype. Muscle Nerve 2007;35:681-4.
9. Brais B, Bouchard JP, Xie YG,et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 1998;18:164-7.
10. Mirabeila M, Silvestri G, de Rosa G,et al. GCG genetic expansions in Italian patients with oculopharyngeal muscular dystrophy. Neurology 2000;8:608-14.
11. Hill ME, Creed GA, McMullan TF,et al. Oculopharyngeal muscular dystrophy: phenotypic and genotypic studies in a UK population. Brain 2001;124:522-6.
12. Mullar T, Schroder R, Zierz S. GCG repeats and phenotype in oculopharyngeal muscular dystrophy. Muscle Nerve 2001;24:120-2.
13. Robinson DO, Hammans SR, Read SP,et al. Oculopharyngeal muscular dystrophy (0PMD): analysis of the PABPN1 gene expansion sequence in 86 patients reveals 13 different expansion types and further evidence for unequal recombination as the mutational mechanism. Hum Genet 2005;116:267- 71.
14. Wahle E, Lustig A, Jeno P,et al. Mammalian poly(A)-binding protein II. Physical properties and binding to polynucleotides. J Biol Chem 1993;5(268):2937-45.
15. Cummings CJ, Zoghbi HY. Trinucleotide repeats: mechanisms and pathophysiology. Annu Rev Genomics Hum Genet 2000;1:281-328.
16. Blumen SC, Korczyn AD, Lavoie H,et al. Oculopharyngeal M0 among Bukhara Jews is due to a founder (GCG)9 mutation in the PABP2 gene. Neurology 2000,55:1267-70.
17. Becher MW, Morrison L, Davis LE,et al. Oculopharyngeal muscular dystrophy in Hispanic New Mexicans. JAMA 2001;286:2437- 40.
18. Rodríguez M, Camejo C, Bertoni B,et al. (GCG) 11 founder mutation in the PABPN1 gene of OPMD Uruguayan families. Neuromuscul Disord 2005;15:185-90.
19. Ramirez-Miranda A, Zenteno JC. PAX6 gene intragenic deletions in Mexican patients with congenital aniridia. Mol Vis 2006;12:318-23.
20. Nakamoto M, Nakano S, Kawashima S,et al. Unequal crossing over in unique PABP2 mutations in Japanese patients: a possible cause of oculopharyngeal muscular dystrophy. Arch Neurol 2002;59:474-7.
21. van dor Sluijs BM, van Engelen BG, Hoefsloot LH. Oculopharyngeal muscular dystrophy (OPMD) due to a small duplication in the PABPN1 gene. Hum Mutat 2003;21:553.
22. Robinson DO, Wills AJ, Hammans SR,et al. Oculopharyngeal muscular dystrophy: a point mutation which mimics the effect of the PABPN1 gene triplet repeat expansion mutation. J Med Genet 2006;43:e23.
23. Muller T, Deschauer M, Kolbe-Fehr F,et al. Genetic heterogeneity in 30 German patients with oculopharyngeal muscular dystrophy. J Neurol 2006;253:892-5.
24. de Swart BJ, van der Sluijs BM, Vos AM,et al. Ptosis aggravates dysphagia in oculopharyngeal muscular dystrophy. J Neurol Neurosurg Psychiatry 2006;77:266-8.